July 10, 2013
  • More Home Monitoring/Pharmacy Management Needed for BP Control

    Hypertension control improved for patients who used home telemonitoring combined with pharmacist management. Even more significant, according to the authors, is that the improvement continued for at least 6 months after the intervention ended. Details follow.

  • Nonhormonal Hot Flash Treatment Will Be Available Later This Year

    Coming to the pharmacy in November: A new, nonhormonal treatment option approved for menopausal women with bothersome hot flashes. The product, Brisdelle, contains the same active ingredient as Paxil and Pexeva, although the dosage is much lower and is dispensed with the same cautions, according to the FDA. Find out more information.

  • NSAID Helps Control Diabetes; Cardiorenal Issues
    Need Research

    The NSAID salsalate showed effectiveness in reducing A1c and fasting blood glucose levels in patients with type 2 diabetes when combined with normal therapies. The authors were not ready to recommend widespread use of the combination, however. What are some of the downsides of the drug regimen?

  • Chinese Study: Two-Drug Combo Reduces Risk of Subsequent Strokes

    A new study has found that a combination of two anticlotting drugs—clopidogrel and aspirin—can decrease by almost a third the risk of a subsequent stroke. The clinical trial, which involved more than 5,000 Chinese patients, is almost identical to a similar study being performed in the United States. Here is what he researchers and a commentator had to say.

U.S. Pharmacist Social Connect